This study validates a computational method that could be applied to diagnosis, prognosis or predictions in a wide variety of immune-mediated diseases
Conditions
Interventions
Group 1: This is a single arm observational study. Clinical results and a peripheral blood sample were obtained from healthy blood donors at a single timepoint before donation. Blood samples were anal
Sponsors
University Hospital Regensburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Eligibility for thrombocyte donation in the Department of Transfusion Medicine at UKR
Exclusion criteria
Exclusion criteria: No additional criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No conventional primary endpoint was defined. The objective of this study was to collect information about peripheral blood T cell distributions that could be used to predict a variety of clinical features of the donors or blood products obtained from those donors; in particular, we focus on predicting CMV-IgG serostatus, age and recorded sex. | — |
Secondary
| Measure | Time frame |
|---|---|
| In addition to CMV-IgG serostatus, age and recorded sex, the following demographic and clinical results are recorded for each donor: ABO, RHD, Kell, IABS, HCV_PCR, HIV_PCR, HBV_PCR, HEV_PCR, WNV_PCR, A_AB, B_AB, WBC, RBC, HB, HCT, MCV, MCH, MCHC, PLT, RDWSD, RDWCV, PDW, MPV, NEUT_p, LYMPH_p, MONO_p, EOS_p, BASO_p, IGS_p, NRBC_p, RETI_p, NEUT_c, LYMPH_c, MONO_c, EOS_c, BASO_c, IGS_c, NRBC_c | — |
Countries
Germany
Contacts
Public ContactJames Alexander Hutchinson
University Hospital Regensburg
Outcome results
None listed